Navigation Links
Perfusion bioreactor could enhance stem cell research and application in the future

Florida State University researchers have now developed a new medical device that is believed to allow bone marrow derived stem cells to be grown in sufficient quantities to permit far more research and allow faster growth of// tissues. This overcomes the currently involved technical difficulties in the growth and transplantation of stem cells. The device called a perfusion bioreactor is designed to mimic conditions encountered by adult stem cells within the human body. The protein rich fluid produced by the reactor bathes the stem cell samples to provide nourishment by a parallel simulation of circulatory system. The perfusion bioreactor allows the delivery of essential nutrients in a physiological way. Furthermore, the researchers hope to alter the fate of each stem cell by altering the nutrient flow. If this is appropriately designed, the stem cell can give rise to a blood cell, nerve cell or a skin cell depending on the need. The stem cells derived from mesenchymal cells and processed in the bioreactor are viable for a period of 40 days and can be directed to differentiate into bone, cartilage, muscle, heart muscle, fat or nerve tissue. The stem cells produced in this way are ideally suitable for clinical transplantation. The current development overcomes the need of using fetal or embryonic tissue and eliminates the ethical concerns associated with the same as the mesenchymal stem cells can be extracted from adult donors. The stem cells for the present study were extracted through a medical procedure in which a small amount of bone marrow is extracted from the donors’ pelvic bone. Within that extracted bone marrow, only about one in every 100,000 cells is a stem cell. The rarity of finding bone marrow derived adult stem cell and technical difficulties involved in growth and multiplication of the stem cells posed a significant challenge to the researchers. However, the research team successfully overcame these shortcomings to achieve the desired resul ts. The present study may eventually pave way for significant breakthroughs in the field of stem cell research and application and help advance the development of numerous medical therapies in the years to come.
'"/>




Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Beware of the oral patch! It could be cancer!!!
3. Prozac miracle could end in disaster
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... ... 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments because ... Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer three ... more sedation methods may be recommended based on the severity of the anxiety experienced ...
(Date:5/22/2017)... , ... May 22, 2017 , ... An inventor from ... with a pen. "My wife’s hand was damaged in a firework accident, so she ... helps people with manual problems." , He then designed and created a prototype for ...
(Date:5/22/2017)... ... May 22, 2017 , ... Faithfully following pop culture, people today are ... toned and shaped through fitness programs. It carries on to skin nourished, pampered and ... an irresistible, radiant smile. CDA has found that just like a perfectly ...
(Date:5/21/2017)... ... , ... Chris Cornell, 52, was found dead on the night of Wednesday, May 17, 2017. ... singers in the rock industry would take his own life, but the extremely talented and ... illness played a role in the death of Chris Cornell . , Depression and ...
(Date:5/21/2017)... Viejo, CA (PRWEB) , ... May 20, 2017 ... ... self-animating, paragraph styled corporate text designs created specifically for use in Final Cut ... editing process for all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: